Search Results 101-110 of 17333 for colitis
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis · Overview · Participation eligibility.
This study is designed to evaluate the efficacy and safety of tofacitinib (CP-690,550) in patients with moderate to severe ulcerative colitis who have failed or ...
The study proposes to assess whether compared to placebo, CP-690,550 is effective, safe, and tolerable maintenance therapy in subjects with Ulcerative Colitis ( ...
AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility ...
A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis · Overview.
... ulcerative colitis (UC) who are refractory to or intolerant of TNF inhibitors. Participation eligibility. Participant eligibility includes age, gender, type ...
Rectal corticosteroids are used to treat mild or moderate ulcerative colitis. They also may be used along with systemic (oral or injection) corticosteroids or ...
Budesonide rectal foam is used to help get mild to moderate active ulcerative colitis that extends from the rectum to the sigmoid colon under control (induce ...
Spastic colon is an outdated term that's sometimes used to refer to irritable bowel syndrome (IBS). IBS is a common digestive condition involving belly ...
... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.